1. Targeting p38 or MK2 enhances the anti-leukemic activity of Smac-Mimetics
- Author
-
Lalaoui, Najoua, Hänggi, Kay, Brumatti, Gabriela, Chau, Diep, Nguyen, Nhu-Y. N., Vasilikos, Lazaros, Spilgies, Lisanne M., Heckmann, Denise A., Ma, Chunyan, Ghisi, Margherita, Salmon, Jessica M., Matthews, Geoffrey M., de Valle, Elisha, Moujalled, Donia M., Menon, Manoj B., Spall, Sukhdeep Kaur, Glaser, Stefan P., Richmond, Jennifer, Lock, Richard B., Condon, Stephen M., Gugasyan, Raffi, Gaestel, Matthias, Guthridge, Mark, Johnstone, Ricky W., Munoz, Lenka, Wei, Andrew, Ekert, Paul G., Vaux, David L., Wong, W. Wei-Lynn, Silke, John, Lalaoui, Najoua, Hänggi, Kay, Brumatti, Gabriela, Chau, Diep, Nguyen, Nhu-Y. N., Vasilikos, Lazaros, Spilgies, Lisanne M., Heckmann, Denise A., Ma, Chunyan, Ghisi, Margherita, Salmon, Jessica M., Matthews, Geoffrey M., de Valle, Elisha, Moujalled, Donia M., Menon, Manoj B., Spall, Sukhdeep Kaur, Glaser, Stefan P., Richmond, Jennifer, Lock, Richard B., Condon, Stephen M., Gugasyan, Raffi, Gaestel, Matthias, Guthridge, Mark, Johnstone, Ricky W., Munoz, Lenka, Wei, Andrew, Ekert, Paul G., Vaux, David L., Wong, W. Wei-Lynn, and Silke, John
- Published
- 2016